15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering NetEase Inc, 2 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $132.00 to $190.00, a moderate spread. The average target of $160.00 sits 26% above the current $127.35. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $15.64 next quarter toward $71.61 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Moderate Buy
Strong Buy00%
Buy267%
Hold133%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to NetEase Inc.
As of Jul, 2 of 3 firms rate NTES a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
NTES EPS & revenue forecast
EPS · NEXT QUARTER
$15.64
Range $14.34 – $17.30 · 9 analysts · +6% YoY
Next period, 9 analysts expect NetEase Inc to earn $15.64 a share (range $14.34 – $17.30), versus $14.73 a year earlier. Full-year consensus is $64.72, growing to $71.61 the year after.
REVENUE · NEXT QUARTER
$30.7B
Range $29.8B – $31.2B · 9 analysts · +8% YoY
Revenue is expected to reach $30.7B (range $29.8B – $31.2B), +8.2% year-over-year. Full-year consensus is $120.9B, rising to $130.3B next year.
Top analysts covering NetEase Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on NTES.
#1
Jiong Shao
Barclays · Rank #43
Hold
$132.00+3.7% to target
Overall win rate
51%
+ Follow
#2
FJ
Fawne Jiang
Benchmark · Rank #273
Buy
$158.00+24.1% to target
Overall win rate
41%
+ Follow
#3
Alicia Yap
Citigroup · Rank #318
Buy
$165.00+29.6% to target
Overall win rate
32%
+ Follow
#4
DC
Daniel Chen
JP Morgan
Buy
$190.00+49.2% to target
Coverage
—
+ Follow
#5
YL
Yang Liu CFA
Morgan Stanley
Buy
$154.00+20.9% to target
Coverage
—
+ Follow
NTES stock forecast FAQ
What is NTES's average 12-month price target?+
The 3 analysts with a live target average $160.00 for NetEase Inc over the next 12 months, ranging from a $190.00 high to a $132.00 low.
Is NTES stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 3 analyst ratings, 2 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for NTES?+
The Street-high target is $190.00 (JP Morgan), and the Street-low is $132.00 (Barclays). The average of all 3 active targets is $160.00.
How many Wall Street analysts cover NTES?+
3 analysts have an active rating on NetEase Inc, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering NTES?+
Among analysts who currently cover NTES, Jiong Shao of Barclays has the strongest overall Quantellect track record (Rank #43). Their current call is Hold with a $132.00 target.
What is NetEase Inc's projected EPS for next quarter?+
The consensus estimate is $15.64 per share (range $14.34 – $17.30) across 9 analysts. Full-year EPS is projected at $64.72, rising to $71.61 the following year.
How much revenue is NetEase Inc expected to report next quarter?+
Consensus revenue is $30.7B (range $29.8B – $31.2B). Full-year revenue is projected at $120.9B, growing to $130.3B next year.
Have analysts been upgrading or downgrading NTES lately?+
As of Jul, 2 of 3 firms rate NTES a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their NTES calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
